Citius Oncology, Inc. SEC filings CTOR
Citius Oncology, Inc. has 268 filings in SEC EDGAR's recent list, going back to May 19, 2021. Its latest annual report, Form ARS, was filed on Aug 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Aug 14, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| 424B3 | Prospectus | Jun 1, 2026 | — |
| S-3 | Shelf registration | May 29, 2026 | — |
| 424B3 | Prospectus | May 22, 2026 | — |
| 424B3 | Prospectus | May 6, 2026 | — |
| 424B3 | Prospectus | May 5, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Feb 20, 2026 | — |
| S-3 | Shelf registration | Jan 5, 2026 | — |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| S-8 | Employee stock plan registration | Sep 19, 2025 | — |
| 424B3 | Prospectus | Sep 10, 2025 | — |
| 424B5 | Prospectus supplement | Sep 10, 2025 | — |
| S-3 | Shelf registration | Sep 2, 2025 | — |
| 424B3 | Prospectus | Aug 18, 2025 | — |
| 424B4 | Prospectus | Jul 17, 2025 | — |
| S-1/A | Amended registration statement | Jul 14, 2025 | — |
| S-1 | Registration statement | Jul 14, 2025 | — |
| 424B3 | Prospectus | Jul 12, 2024 | — |
| S-4/A | Filing | Jul 11, 2024 | — |
| S-4/A | Filing | Jul 11, 2024 | — |
| S-4/A | Filing | Jun 17, 2024 | — |
| S-4/A | Filing | May 3, 2024 | — |
| S-4/A | Filing | Jan 30, 2024 | — |
| S-4 | Registration for a merger or exchange | Nov 13, 2023 | — |
| 424B4 | Prospectus | Oct 14, 2022 | — |
| S-1/A | Amended registration statement | Sep 12, 2022 | — |
| S-1/A | Amended registration statement | Jul 29, 2022 | — |
| S-1/A | Amended registration statement | May 24, 2022 | — |
| S-1/A | Amended registration statement | May 11, 2022 | — |
| S-1/A | Amended registration statement | Apr 1, 2022 | — |
| S-1/A | Amended registration statement | Mar 8, 2022 | — |
| S-1/A | Amended registration statement | Aug 20, 2021 | — |
| S-1/A | Amended registration statement | Jun 30, 2021 | — |
| S-1 | Registration statement | May 19, 2021 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTOR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Cranford, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1851484
- Former names
- TenX Keane Acquisition (until Aug 5, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.